✦ LIBER ✦

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

✍ Scribed by Widemann, B. C.; Dombi, E.; Gillespie, A.; Wolters, P. L.; Belasco, J.; Goldman, S.; Korf, B. R.; Solomon, J.; Martin, S.; Salzer, W.; Fox, E.; Patronas, N.; Kieran, M. W.; Perentesis, J. P.; Reddy, A.; Wright, J. J.; Kim, A.; Steinberg, S. M.; Balis, F. M.

Book ID: 121748999
Publisher: Duke University Press
Year: 2014
Tongue: English
Weight: 443 KB
Volume: 16
Category: Article
ISSN: 1522-8517
DOI: 10.1093/neuonc/nou004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Tolerability of a 20-mg Dos

Efficacy and Tolerability of a 20-mg Dose of Methylphenidate for the Treatment of Daytime Sleepiness in Adult Patients With Myotonic Dystrophy Type 1: A 2-Center, Randomized, Double-Blind, Placebo-Controlled, 3-Week Crossover Trial

✍ Jack Puymirat; Jean-Pierre Bouchard; Jean Mathieu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 311 KB

A randomized double blind, placebo contr

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis

✍ Konstan, M.W.; Döring, G.; Heltshe, S.L.; Lands, L.C.; Hilliard, K.A.; Koker, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 392 KB

Linagliptin, a dipeptidyl peptidase-4 in

Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects

✍ Akiko Sarashina; Shogo Sesoko; Mitsuyoshi Nakashima; Naoyuki Hayashi; Atsushi Ta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 212 KB